PMDA — authorised 23 January 2006
- Marketing authorisation holder: SERONO JAPAN
- Status: approved
PMDA authorised Urofollitropin on 23 January 2006
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 23 January 2006.
SERONO JAPAN holds the Japanese marketing authorisation.